Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04916522 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The COlchicine HypERtENsion Trial

Study acronym: COHERENT
StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 22, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: Dec 2024 to Jan 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v5
  2. Primary and study completion dates: Dec 2023 to Dec 2024v4
  3. Start date changed from estimate of Jul 2021 to Aug 10, 2021v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Jun 2021 to Jul 2021
    • Site details revised
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study to investigate the effects of colchicine on measures of vascular and cardiac function in patients with hypertension.
Trial Details
NCT Number NCT04916522
Lead Sponsor Herlev and Gentofte Hospital
Collaborators: University of Copenhagen
Conditions
(from sponsor)		 Hypertension
Related terms Atherosclerosis, Cardiovascular Diseases, Coronary Artery Disease, Endomyocardial Fibrosis, Heart Diseases, Hypertension, Hypertrophy, Left Ventricular, Inflammation
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov